BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 19351641)

  • 1. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
    Black PN; McDonald CF
    Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.
    Niewoehner DE
    Am J Med; 2006 Oct; 119(10 Suppl 1):38-45. PubMed ID: 16996898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tiotropium in the prevention of exacerbations of COPD.
    Anzueto A; Miravitlles M
    Ther Adv Respir Dis; 2009 Jun; 3(3):103-11. PubMed ID: 19617284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic obstructive pulmonary disease].
    Fernández-Fernández FJ; Ameneiros-Lago E; González Moraleja J; Pía Iglesias G; Martínez-Debén FS; Sesma P
    An Med Interna; 2003 Mar; 20(3):148-55. PubMed ID: 12756902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS; Carnathan BJ; Imus S; Colice GL
    Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease].
    Corhay JL; Louis R
    Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
    Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
    Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
    COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of steroids in the treatment of COPD].
    Reynard C
    Rev Med Suisse; 2007 Feb; 3(99):457-8, 460-1. PubMed ID: 17424796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
    Davies L; Calverley PM
    Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD: management of acute exacerbations and chronic stable disease.
    Hunter MH; King DE
    Am Fam Physician; 2001 Aug; 64(4):603-12. PubMed ID: 11529259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.